Subscribe
A dynamic partnership has resulted in the development of a new, minimally-invasive device that can be used to treat HIV, cancer, and a number of other disease, ensuring medicinal adherence.
Is it Cost Effective to Preemptively Treat People at High Risk of HIV Infection?
Europe's Plan to Tackle Undiagnosed HIV
Study Finds High Prevalence of Multidrug-resistant HIV
California Set On "Getting to Zero" When it Comes to HIV
July 28, 2026
Solange Peters, MD, PhD; Benjamin P. Levy, MD; Tony S.K. Mok, MD, BMSc, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO; Maurice Pérol, MD
Solange Peters, MD, PhD; Myung-Ju Ahn, MD, PhD; Luis Paz-Ares, MD, PhD; Jacob Sands, MD
Solange Peters, MD, PhD; Stephanie McDonald, FNP-BC, AOCNP; Antonio Passaro, MD, PhD; Jacob Sands, MD